Miglustat Dipharma Den Europæiske Union - dansk - EMA (European Medicines Agency)

miglustat dipharma

dipharma arzneimittel gmbh - miglustat - gaucher sygdom - andre fordøjelseskanaler og stofskifteprodukter - miglustat dipharma er angivet for den mundtlige behandling af voksne patienter med mild til moderat type 1 gaucher sygdom. miglustat dipharma kan kun anvendes i behandling af patienter, for hvem enzymsubstitutionsbehandlingen er uegnet. miglustat dipharma er indiceret til behandling af progressive neurologiske forstyrrelser hos voksne patienter, og pædiatriske patienter med niemann-picks sygdom type c.

Vaxzevria (previously COVID-19 Vaccine AstraZeneca) Den Europæiske Union - dansk - EMA (European Medicines Agency)

vaxzevria (previously covid-19 vaccine astrazeneca)

astrazeneca ab - chadox1-sars-cov-2 - covid-19 virus infection - vacciner - vaxzevria is indicated for active immunisation to prevent covid 19 caused by sars cov 2, in individuals 18 years of age and older. brug af denne vaccine bør være i overensstemmelse med de officielle anbefalinger.

Prevexxion RN Den Europæiske Union - dansk - EMA (European Medicines Agency)

prevexxion rn

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease (md) virus, serotype 1, strain rn1250 - immunologicals for aves - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus).

Prevexxion RN+HVT+IBD Den Europæiske Union - dansk - EMA (European Medicines Agency)

prevexxion rn+hvt+ibd

boehringer ingelheim vetmedica gmbh - live recombinant marek’s disease virus, serotype 1, strain rn1250; live recombinant turkey herpesvirus, expressing the vp2 protein of infectious bursal disease virus, strain vhvt013-69 - immunologicals for aves, domestic fowl, avian herpes virus (marek's disease) + avian infectious bursal disease virus (gumboro disease) + newcastle disease virus/paramyxovirus - kylling - for active immunisation of one-day-old chicks to prevent mortality and clinical signs and reduce lesions caused by marek’s disease (md) virus (including very virulent md virus), and to prevent mortality, clinical signs and lesions caused by infectious bursal disease (ibd) virus.

Spiriva Respimat 2,5 mikrogram inhalationsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

spiriva respimat 2,5 mikrogram inhalationsvæske, opløsning

boehringer ingelheim int. gmbh - tiotropiumbromidmonohydrat - inhalationsvæske, opløsning - 2,5 mikrogram

Spiriva Respimat 2,5 mikrogram inhalationsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

spiriva respimat 2,5 mikrogram inhalationsvæske, opløsning

paranova danmark a/s - tiotropium bromid - inhalationsvæske, opløsning - 2,5 mikrogram

Spiriva Respimat 2,5 mikrogram inhalationsvæske, opløsning Danmark - dansk - Lægemiddelstyrelsen (Danish Medicines Agency)

spiriva respimat 2,5 mikrogram inhalationsvæske, opløsning

2care4 aps - tiotropiumbromidmonohydrat - inhalationsvæske, opløsning - 2,5 mikrogram

Celvapan Den Europæiske Union - dansk - EMA (European Medicines Agency)

celvapan

nanotherapeutics bohumil, s.r.o. - whole virion influenza vaccine, inactivated containing antigen of strain a/california/07/2009 (h1n1)v - disease outbreaks; influenza, human; immunization - vacciner - profylakse af influenza forårsaget af a (h1n1) v 2009 virus. celvapan bør anvendes i overensstemmelse med officielle retningslinjer.